Research & Innovation

New Edition of research - the Bayer scientific magazine

Tackling devastating diseases

Cardiovascular disease, cancer and Alzheimer’s are just three of the many conditions of our time that have devastating consequences. Early diagnosis and therapy of these diseases still represent two of the greatest challenges facing scientists and physicians. And despite the major progress being made in their treatment, there is still a huge need for research to, on the one hand, make it possible to diagnose these diseases more effectively and at an earlier stage and, on the other, minimize the consequences for those affected, develop innovative therapies and thus improve patients’ quality of life and prolong their survival. » more

Heart failure

Alzheimer’s

Non-Hodgkin’s lymphoma

Cancer

Video Podcast
New technologies help cancer patients
At the Annual Meeting of U.S. oncologists, Bayer presented the most recent data on its anticancer active ingredient sorafenib – a success story.

7:20 min.

Video Podcast
Bayer’s Perspective on Innovation 2008
Topical information on research and development activities and future research strategy » more

6:36 min.

Video Podcast
New crop protection product to control insect pests
A new active ingredient is the first to be distributed evenly throughout the entire plant via the sap, providing protection against sucking insects.

5:50 min.

News

October 29, 2009

Agreement on yield enhancement and abiotic stress tolerance:
Bayer CropScience and Scivax Corporation sign research cooperation and exclusive license option » more

News Overview